The global health industry system evaluation center formulates international evaluation standards for the health industry to evaluate the top 100 global health industries, selects influential figures in the global health industry, and evaluates global health industry demonstration zones.
Hangzhou Qiantang New Area
In April, 2019, Hangzhou Qiantang New Area, including Hangzhou Dajiangdong Industry Cluster Zone and Hangzhou Economic and Technological Development Area, was approved to establish by Zhejiang Provincial People’s Government. The Area boasts three state-level honors—Hangzhou Economic and Technological Development Area, Hangzhou Comprehensive Bonded Area and Linjiang High-tech Industrial Development Zone.
Hangzhou Qiantang New Area has gathered lots of key enterprises, such as Pfizer, MSD, Abbott, Huadong Medicine, Mary kay and so on. Besides, there are a number of major projects under construction, including Huahai Medicine, Jiuzhou, AllTest Biotech, etc. In the future, Hangzhou Qiantang New Area will focus on bio-pharmaceutical, medical apparatus and instruments, biomedical engineering and medical big data, aiming to create an industry cluster with output value of 100 bn Yuan.
Cambridge, Boston, USA
Massachusetts Gov. Charlie Baker (R) in June recommitted his state to helping grow its biopharma industry, anchored in Boston and Cambridge, MA, by reauthorizing the Massachusetts Life Sciences Initiative. The $623 million in bonds and tax credits authorized over five years is smaller than the $1 billion, decade-long measure enacted in 2007 by then-Gov. Deval Patrick (D), though the state says it remains as focused as ever on industry growth.
Eighteen of the top 20 biopharmas have a major presence in Boston/Cambridge, and the region continues to welcome companies of all sizes: Alexandria Real Estate Equities this fall will open its second LaunchLabs startup accelerator in Cambridge, as Takeda Pharmaceutical prepares to move its U.S. HQ to Boston/Cambridge (See Chicagoland above). Cambridge-based Moderna Therapeutics in July opened a $110 million site in suburban Norwood, MA. Cambridge this year welcomed expansion plans by AbbVie, among numerous companies, and the openings of Fujifilm Diosynth’s new collaboration center and Thermo Fisher’s U.S. Precision Medicine Science Center.
City of Kobe- KBIC
KBIC, the largest biomedical cluster in Japan, is the innovation arm of the City of Kobe to foster innovation and collaboration among its members and affiliates to ensure a thriving biomedical industry.
KBIC currently boasts a concentrated network of close to about 370 companies, universities and research institutes, and specialized hospitals, in addition to a growing network of international biocluster partners, who are all focused on the development of innovative medical technology and pioneering discoveries through collaboration. Leading institutes at KBIC include Riken Center for Biosystems Dynamics Research, Japan’s largest comprehensive research organization. Our corporate members range from promising startups, such as Bio Palette, to leading multinational healthcare giants, such as Boehringer Ingelheim. Click here for more details.
Planing area 79.7 square kilometers, Through strong innovation atmosphere, a plurality of talent accumulation, powerful innovation platform, ZJ Park attracted a large number of top hi-tech enterprises and small-mediun sized innovative enterprises, and is the birth place of new technology , new pattern and new format.
Global Health Industry Top 100
Global factors drive dramatic changes in the health industry. In order to summarize laws of major changes in the technology system, production mode, organizational form in global health industry, create a vibrant and dynamic cooperation and exchange platform and optimize resources allocation for the global health industry, Asia-Pacific CEO Association (APCEO), a well-known international economic organization, has launched the global health industry cooperation system.
Members of the global health industry cooperation system are mainly the world's leading healthcare and biotechnology companies shortlisted in the Fortune global 500, Forbes global 2000, global industry investment top 100, global industry innovation top 100, and global top 500 investment companies.
To further analyze the structure and development trend of global health industry, the APCEO has integrated opinions from over 20 experts and economists in health industry from the world's top academic institutions such as the Academia Europaea, MIT, Harvard, got professional evaluation and recognition and formed the Global Health Industry Top 100 ranking. It was officially promulgated as an important achievement of the global health industry cooperation system on the occasion of the Global Health Industry Cooperation Conference.
The ranking of Global Health Industry Top 100 is mainly based on the operating quality indexes of enterprises worldwide in health sector, such as sales yield, ROE, production efficiency in the past three years, as well as market value, profitability, enterprise scale, social influence, and their investment, research, achievements, and growth potential.
Health industry is an emerging industry with huge market potential, covering many production and service fields closely related to people’s health, such as bio-pharmaceutical, medical devices, medical testing, biological vaccine, precision treatment, high-end medical treatment, health management services, health products, rehabilitation and recuperation, health care and aged care, international medical tourism, etc.
The ranking of Global Health Industry Top 100 will help to better understand the pattern, resource allocation and strategic direction of health industries.
|1||Johnson & Johnson||United States|
|2||UnitedHealth Group||United States|
|3||CVS Health||United States|
|6||General Electric||United States|
|11||Merck & Co.||United States|
|19||Bristol-Myers Squibb||United States|
|20||Walgreens Boots Alliance||United States|
|23||Thermo Fisher Scientific||United States|
|24||Gilead Sciences||United States|
|26||Eli Lilly||United States|
|27||HCA Healthcare||United States|